جدول الترويج enVVeno Medical Corporation
الجدول الزمني المتقدم
رسم بياني بسيط
عن الشركة enVVeno Medical Corporation
enVVeno Medical Corporation, a clinical med-tech company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of chronic venous disease. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. مزيد من التفاصيل| IPO date | 2018-05-31 |
|---|---|
| ISIN | US29415J1060 |
| Industry | Health Care Equipment & Supplies |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.envveno.com |
| Цена ао | 2.9 |
| تغير السعر يوميا: | -2.83% (2.83) |
|---|---|
| تغير السعر في الأسبوع: | -7.72% (2.98) |
| تغير السعر شهريا: | -22.1% (3.53) |
| تغير السعر خلال 3 أشهر: | -12.7% (3.15) |
| تغير السعر على مدى ستة أشهر: | -18.15% (3.36) |
| تغير السعر سنويا: | -49.45% (5.44) |
| تغير السعر على مدى 3 سنوات: | -45% (5) |
| تغير السعر على مدى 5 سنوات: | +284.62% (0.715) |
| تغير الأسعار منذ بداية العام: | -10.13% (3.06) |
|
|
الاستهانة
|
كفاءة
|
|||||||||||||||||||||||||||||||||||||
توزيعات الأرباح
|
واجب
|
دافع النمو
|
|||||||||||||||||||||||||||||||||||||
| المؤسسات | مقدار | يشارك, % |
|---|---|---|
| Nantahala Capital Management, LLC | 1412638 | 10.61 |
| Perceptive Advisors LLC | 623315 | 4.68 |
| Kingdon Capital Management LLC | 619180 | 4.65 |
| Armistice Capital, LLC | 436000 | 3.27 |
| Altium Capital Management, LP | 344471 | 2.59 |
| Vanguard Group Inc | 336405 | 2.53 |
| Rosalind Advisors, Inc. | 312091 | 2.34 |
| UBS OConnor LLC | 236308 | 1.77 |
| Velan Capital Investment Management LP | 172235 | 1.29 |
| Geode Capital Management, LLC | 122116 | 0.92 |
| ETF | يشارك, % | الربحية لهذا العام, % | توزيعات الأرباح, % |
|---|---|---|---|
| iShares Micro-Cap ETF | 0.01259 | 17.09 | 1.54048 |
| 0.01 | 17.09 | 1.54 |
| مشرف | مسمى وظيفي | قسط | سنة الميلاد |
|---|---|---|---|
| Mr. Robert A. Berman | CEO & Director | 1.02M | 1963 (62 سنة) |
| Mr. Craig Thomas Glynn | CFO, Treasurer & Secretary | 313.69k | 1961 (64 سنة) |
| Dr. Hamed Alavi Ph.D. | Senior VP & Chief Technology Officer | 384.39k | |
| Dr. Marc H. Glickman M.D. | Senior VP & Chief Medical Officer | 491.59k | 1949 (76 سنين) |
| Mr. Warren Hancock | Co-founder | N/A | |
| Dr. Benedict Broennimann M.D. | Chief Medical Officer of Outside of United States | 240k | 1957 (68 سنين) |
| Mr. Andrew Cormack | Chief Commercial Officer | N/A | |
| Ms. Sandy Prietto | Vice President of Marketing |
عنوان: United States, Irvine. CA, 70 Doppler - مفتوحة في خرائط جوجل, فتح خرائط ياندكس
موقع إلكتروني: https://www.envveno.com
موقع إلكتروني: https://www.envveno.com
